Gastroparesis Global Market Report 2025

Description

Gastroparesis is a medical condition characterized by the impairment or weakening of the stomach muscles, leading to the delayed emptying of stomach contents into the small intestine. The treatment of gastroparesis involves medications aimed at stimulating stomach emptying, managing underlying conditions, and surgical interventions.

The primary treatment modalities for gastroparesis include medications, dietary modifications, medical devices, and other approaches. Medications are substances that interact with the body's biological processes to produce a desired effect. Prokinetic drugs, antiemetics, botulinum toxin injections, antidepressants, and other medications are utilized to diagnose, treat, cure, or prevent gastroparesis. These medications are employed in the treatment of various types of gastroparesis, including idiopathic, diabetic, post-surgical, and others, in both pediatric and adult patients. They are distributed through retail pharmacies, hospital pharmacies, and other channels, making them accessible to hospitals and clinics, ambulatory surgical centers, and home care settings.

The gastroparesis research report is one of a series of new reports from The Business Research Company that provides gastroparesis market statistics, including the gastroparesis industry's global market size, regional shares, competitors with gastroparesis market share, detailed gastroparesis market segments, market trends and opportunities, and any further data you may need to thrive in the gastroparesis industry. This gastroparesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gastroparesis market size has grown steadily in recent years. It will grow from $6.84 billion in 2024 to $7.17 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to aging population, increasing prevalence of diabetes, improved understanding of gastrointestinal disorders, evolving treatment protocols, growing awareness about gastroparesis

The gastroparesis market size is expected to see strong growth in the next few years. It will grow to $8.82 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to development of novel therapeutic options, expansion of personalized medicine approaches, integration of digital health solutions, rise in healthcare infrastructure, increasing focus on early diagnosis. Major trends in the forecast period include advancements in gastric electrical stimulation therapy, growing research in stem cell therapy, adoption of minimally invasive surgical interventions, increased use of wearable health monitoring devices, focus on patient-centric care models.

The anticipated growth in healthcare expenditure is expected to drive the expansion of the gastroparesis market in the coming years. Healthcare expenditure encompasses the total resources allocated to health services, including costs associated with hospitals, medical professionals, nursing, dental care, medications, and public health initiatives. Factors such as an aging population, advancements in medical technology, an increasing prevalence of chronic diseases, and heightened consumer expectations for enhanced healthcare services contribute to the rise in healthcare spending. This increase benefits the gastroparesis market by providing additional financial support for research and development, broadening treatment options, and improving patient access to specialized healthcare services. For instance, a report from the Office for National Statistics, a UK-based government department, indicated that healthcare spending in the UK rose by 5.6% from 2022 to 2023, compared to a growth rate of 0.9% in 2022. In 2023, the UK's healthcare expenditure reached approximately $317.63 billion (£292 billion). Thus, the growth in healthcare expenditure is propelling the gastroparesis market.

The rapid increase in diabetes prevalence is projected to drive the growth of the gastroparesis market in the future. Diabetes is a chronic medical condition characterized by elevated blood glucose levels due to the body's inability to produce sufficient insulin or utilize the insulin it does produce effectively. The rise in diabetes cases significantly heightens the risk of developing gastroparesis, as diabetes is a key factor contributing to the at-risk population for this condition. For example, data from the Australian Bureau of Statistics, an Australian government agency, revealed that in 2022, 5.3% of the Australian population (approximately 1.3 million individuals) had diabetes, a significant increase from 3.3% in previous years. Consequently, the rapid surge in diabetes prevalence is fueling the growth of the gastroparesis market.

The anticipated growth of the gastroparesis market is expected to be driven by the increasing proportion of aging individuals. Aging individuals refer to those who are advancing in age or undergoing the aging process. The aging population significantly impacts the gastroparesis market due to an elevated prevalence among older individuals, associations with age-related conditions, and distinctive challenges in diagnosing and managing gastroparesis in the elderly. For example, in June 2023, the United States Census Bureau, a US-based government agency, reported a 0.2-year increase in the country's median age to 38.9 years in 2022 from 2021 to 2022, indicating a continued aging trend in the population. Hence, the growing proportion of aging individuals is propelling the gastroparesis market.

Major companies in the gastroparesis market are investing in innovative devices to enhance their market position and profitability. Devices designed for gastroparesis treatment are medical tools or equipment aimed at managing or alleviating symptoms related to delayed stomach emptying. For instance, in 2022, Enterra Medical Inc., a US-based medical device company, introduced the Enterra Therapy for treating gastroparesis. The Enterra Therapy system utilizes an implanted neurostimulator to deliver gentle electrical pulses, offering potential relief for symptoms such as chronic nausea and vomiting associated with gastroparesis. This therapy is intended for individuals aged 18 to 70 experiencing chronic, intractable (drug-refractory) nausea and vomiting linked to gastroparesis of diabetic or idiopathic origin.

Major companies in the gastroparesis market are also developing drugs to bolster their profitability. Drugs used in gastroparesis treatment serve various purposes to address symptoms associated with delayed stomach emptying. For example, in December 2023, Vanda Pharmaceuticals Inc., a US-based biopharmaceutical company, announced that the U.S. FDA had accepted the New Drug Application for Tradipitant. This development represents a significant step toward potential approval for treating gastroparesis, with the FDA setting the decision date for Tradipitant under the Prescription Drug User Fee Act (PDUFA) on September 18, 2024. If successful, Tradipitant would be the first FDA-approved novel drug for gastroparesis in over 40 years, marking a significant milestone in more than three decades for a drug specifically undergoing FDA review for gastroparesis.

Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastroparesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastroparesis market consists of sales of metoclopramide, domperidone, and erythromycin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastroparesis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastroparesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastroparesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastroparesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Modality: Medications; Dietary Modifications; Medical Devices; Other Therapies
2) By Gastroparesis Type: Idiopathic; Diabetic; Post- Surgical; Other Types
3) By Patient Demographics: Pediatric Gastroparesis; Adult Gastroparesis
4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Other Distribution Channels
5) By End User: Hospitals And Clinics; Ambulatory Surgical Centers; Home Care Settings
Subsegments:
1) By Medications: Prokinetic Agents; Antiemetic Medications; Pain Management Medications
2) By Dietary Modifications: Low-Fiber Diets; Small, Frequent Meals; Pureed Or Liquid Diets
3) By Medical Devices: Gastric Electrical Stimulation Devices; Enteral Feeding Tubes
4) By Other Therapies: Acupuncture; Behavioral Therapies; Nutritional Supplements
Companies Mentioned: Pfizer Inc.; GlaxoSmithKline plc.; Abbott Laboratories Inc.; AstraZeneca Plc.; Medtronic Plc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24965

1. Executive Summary

2. Gastroparesis Market Characteristics

3. Gastroparesis Market Trends And Strategies

4. Gastroparesis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Gastroparesis Growth Analysis And Strategic Analysis Framework

5.1. Global Gastroparesis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gastroparesis Market Growth Rate Analysis
5.4. Global Gastroparesis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gastroparesis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gastroparesis Total Addressable Market (TAM)

6. Gastroparesis Market Segmentation

6.1. Global Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Dietary Modifications
Medical Devices
Other Therapies
6.2. Global Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Idiopathic
Diabetic
Post-Surgical
Other Types
6.3. Global Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric Gastroparesis
Adult Gastroparesis
6.4. Global Gastroparesis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacies
Hospital Pharmacies
Other Distribution Channels
6.5. Global Gastroparesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals and Clinics
Ambulatory Surgical Centers
Home Care Settings
6.6. Global Gastroparesis Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prokinetic Agents
Antiemetic Medications
Pain Management Medications
6.7. Global Gastroparesis Market, Sub-Segmentation Of Dietary Modifications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Low-Fiber Diets
Small, Frequent Meals
Pureed Or Liquid Diets
6.8. Global Gastroparesis Market, Sub-Segmentation Of Medical Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gastric Electrical Stimulation Devices
Enteral Feeding Tubes
6.9. Global Gastroparesis Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acupuncture
Behavioral Therapies
Nutritional Supplements

7. Gastroparesis Market Regional And Country Analysis

7.1. Global Gastroparesis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gastroparesis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastroparesis Market

8.1. Asia-Pacific Gastroparesis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastroparesis Market

9.1. China Gastroparesis Market Overview
9.2. China Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastroparesis Market

10.1. India Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastroparesis Market

11.1. Japan Gastroparesis Market Overview
11.2. Japan Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastroparesis Market

12.1. Australia Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastroparesis Market

13.1. Indonesia Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastroparesis Market

14.1. South Korea Gastroparesis Market Overview
14.2. South Korea Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastroparesis Market

15.1. Western Europe Gastroparesis Market Overview
15.2. Western Europe Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastroparesis Market

16.1. UK Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastroparesis Market

17.1. Germany Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastroparesis Market

18.1. France Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastroparesis Market

19.1. Italy Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastroparesis Market

20.1. Spain Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastroparesis Market

21.1. Eastern Europe Gastroparesis Market Overview
21.2. Eastern Europe Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastroparesis Market

22.1. Russia Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastroparesis Market

23.1. North America Gastroparesis Market Overview
23.2. North America Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastroparesis Market

24.1. USA Gastroparesis Market Overview
24.2. USA Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastroparesis Market

25.1. Canada Gastroparesis Market Overview
25.2. Canada Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastroparesis Market

26.1. South America Gastroparesis Market Overview
26.2. South America Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastroparesis Market

27.1. Brazil Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastroparesis Market

28.1. Middle East Gastroparesis Market Overview
28.2. Middle East Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastroparesis Market

29.1. Africa Gastroparesis Market Overview
29.2. Africa Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastroparesis Market Competitive Landscape And Company Profiles

30.1. Gastroparesis Market Competitive Landscape
30.2. Gastroparesis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca Plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis

31. Gastroparesis Market Other Major And Innovative Companies

31.1. Takeda Pharmaceutical Company Limited
31.2. Johnson And Johnson Services Inc.
31.3. Teva Pharmaceutical Industries Ltd.
31.4. AbbVie Inc.
31.5. Boston Scientific Corporation
31.6. Bausch Health Companies Inc.
31.7. Cadila Pharmaceuticals Ltd.
31.8. Daewoong Pharmaceutical Co. Ltd.
31.9. ReGenXBio Inc.
31.10. ANI Pharmaceuticals Inc.
31.11. Dompe Farmaceutici S.p.A
31.12. Sucampo Pharmaceuticals Inc.
31.13. Ironwood Pharmaceuticals Inc.
31.14. Theravance Biopharma Inc.
31.15. RedHill Biopharma Ltd.

32. Global Gastroparesis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastroparesis Market

34. Recent Developments In The Gastroparesis Market

35. Gastroparesis Market High Potential Countries, Segments and Strategies

35.1 Gastroparesis Market In 2029 - Countries Offering Most New Opportunities
35.2 Gastroparesis Market In 2029 - Segments Offering Most New Opportunities
35.3 Gastroparesis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer